United States · FDA National Drug Code directory
Lisinopril and Hydrochlorothiazide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68788-8253_47539c36-4d1a-4b16-8d38-abc468d048c6
- Product NDC
- 68788-8253
- Form
- TABLET
- Composition / generic term
- Lisinopril and Hydrochlorothiazide Tablets
- Labeler
- Preferred Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20221001
- Source listing expiry
- 20271231
Source-listed ingredients
- LISINOPRIL — 20 mg/1
- HYDROCHLOROTHIAZIDE — 12.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (68788-8253-1) · 68788-8253-1
- 30 TABLET in 1 BOTTLE (68788-8253-3) · 68788-8253-3
- 60 TABLET in 1 BOTTLE (68788-8253-6) · 68788-8253-6
- 90 TABLET in 1 BOTTLE (68788-8253-9) · 68788-8253-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →